These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33912215)

  • 1. Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma.
    Bai Y; Qi W; Liu L; Zhang J; Pang L; Gan T; Wang P; Wang C; Chen H
    Front Genet; 2021; 12():637418. PubMed ID: 33912215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
    Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
    BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Lin Z; Xu Q; Miao D; Yu F
    Front Oncol; 2021; 11():644416. PubMed ID: 33828988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
    Chen S; Zhao E
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
    Li X; Lin J; Pan Y; Cui P; Xia J
    Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
    [No Abstract]   [Full Text] [Related]  

  • 9. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
    Zhu G; Xia H; Tang Q; Bi F
    Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma.
    Lin Z; Xu Q; Song X; Zeng Y; Zeng L; Zhao L; Xu J; Miao D; Chen Z; Yu F
    Front Oncol; 2022; 12():748557. PubMed ID: 35311113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.
    Chen Y; Huang M; Zhu J; Xu L; Cheng W; Lu X; Yan F
    Front Pharmacol; 2022; 13():857060. PubMed ID: 35496321
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma.
    Yuan C; Yuan M; Chen M; Ouyang J; Tan W; Dai F; Yang D; Liu S; Zheng Y; Zhou C; Cheng Y
    Front Oncol; 2021; 11():666199. PubMed ID: 34150630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma.
    Zhu Z; Song M; Li W; Li M; Chen S; Chen B
    Front Oncol; 2021; 11():695001. PubMed ID: 34616672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma.
    Zhu Z; Li L; Xu J; Ye W; Chen B; Zeng J; Huang Z
    PeerJ; 2020; 8():e9201. PubMed ID: 32518728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma.
    Zheng JY; Liu JY; Zhu T; Liu C; Gao Y; Dai WT; Zhuo W; Mao XY; He BM; Liu ZQ
    Front Pharmacol; 2022; 13():895608. PubMed ID: 35924040
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
    Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
    Front Oncol; 2021; 11():629327. PubMed ID: 33718205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
    Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
    BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.